Giotrif Tablets: Product Overview
Giotrif is a prescription oncology medicine containing afatinib, an oral targeted therapy used for specific types of non-small cell lung cancer (NSCLC). It belongs to a group of medicines known as tyrosine kinase inhibitors, which target signalling proteins involved in cancer cell growth.
For patients, caregivers, pharmacies, and pharmaceutical procurement professionals researching Giotrif tablets in Singapore, understanding the product's strengths, approved indications, and safety requirements is essential before considering treatment or sourcing options.
According to Singapore's National Drug Formulary, Giotrif film-coated tablets are registered in three strengths: 20 mg, 30 mg, and 40 mg. Official Singapore product information.
Giotrif Tablets Strengths and Product Details
The following strengths are listed in Singapore's National Drug Formulary:
Giotrif 20 mg tablets: A lower strength that may be prescribed when clinically appropriate.
Giotrif 30 mg tablets: An alternative strength used according to the treating specialist's assessment.
Giotrif 40 mg tablets: The recommended starting dose in the Singapore product information, subject to individual clinical considerations.
Active ingredient: Afatinib (as afatinib dimaleate).
Dosage form: Oral film-coated tablets.
Therapeutic category: Targeted anticancer medicine.
The appropriate strength depends on the patient's diagnosis, tolerability, medical history, and specialist guidance. Patients should not change their dose or strength without consulting their oncologist.
Benefits and Approved Uses of Giotrif
Giotrif works by blocking signalling activity in the ErbB receptor family, including the epidermal growth factor receptor (EGFR). These pathways can contribute to the growth and survival of certain cancer cells.
Its approved uses in Singapore include:
First-line treatment of locally advanced or metastatic NSCLC with qualifying EGFR mutations.
Treatment of locally advanced or metastatic squamous NSCLC that has progressed during or after platinum-based chemotherapy.
The potential benefit is targeted treatment for patients whose cancer characteristics match the approved indication. Treatment suitability should be established through appropriate diagnostic testing and an oncologist's evaluation. Giotrif is not suitable for every type of lung cancer.
Side Effects and Safety Precautions
Common adverse effects may include diarrhoea, skin rash, acne-like skin reactions, mouth inflammation, and reduced appetite. Some reactions may require medical intervention or a dose adjustment.
Seek prompt medical attention for severe or persistent diarrhoea, significant skin reactions, eye problems, or new or worsening breathing difficulties. Serious lung inflammation can occur. Patients should disclose their other medicines and existing medical conditions to their healthcare professional.
Giotrif is a prescription-only medicine in Singapore. Use it strictly according to the approved product information and the prescribing specialist's instructions.
Giotrif Tablets Supply Enquiries in Singapore
Cordium Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company. Healthcare procurement teams and authorised pharmaceutical buyers can contact the company to enquire about product availability, documentation, and potential supply arrangements, subject to applicable regulatory requirements.
Before placing an order, verify the product's registration status, supplier authorisation, product authenticity, batch documentation, and import eligibility in Singapore. Any cross-border supply must comply with applicable Health Sciences Authority (HSA) requirements.
Frequently Asked Questions
1. What strengths of Giotrif tablets are available in Singapore?
The Singapore National Drug Formulary lists Giotrif 20 mg, 30 mg, and 40 mg film-coated tablets.
2. What is Giotrif used for?
It is used for specified forms of locally advanced or metastatic NSCLC, depending on EGFR mutation status or squamous tumour histology and previous treatment.
3. Can I buy Giotrif tablets online in Singapore?
Giotrif is prescription-only. Patients should obtain it through lawful, authorised channels under appropriate medical supervision.
4. Does Cordium Pharmaceuticals supply Giotrif to Singapore?
Contact Cordium Pharmaceuticals Pvt. Ltd. to enquire about current availability and eligible supply arrangements. Product availability and export authorisation should be confirmed before any transaction.
Medical disclaimer: This article is for educational and pharmaceutical product-information purposes only. It does not replace medical advice, a prescription, or regulatory verification.
Giotrif is a prescription oncology medicine containing afatinib, an oral targeted therapy used for specific types of non-small cell lung cancer (NSCLC). It belongs to a group of medicines known as tyrosine kinase inhibitors, which target signalling proteins involved in cancer cell growth.
For patients, caregivers, pharmacies, and pharmaceutical procurement professionals researching Giotrif tablets in Singapore, understanding the product's strengths, approved indications, and safety requirements is essential before considering treatment or sourcing options.
According to Singapore's National Drug Formulary, Giotrif film-coated tablets are registered in three strengths: 20 mg, 30 mg, and 40 mg. Official Singapore product information.
Giotrif Tablets Strengths and Product Details
The following strengths are listed in Singapore's National Drug Formulary:
Giotrif 20 mg tablets: A lower strength that may be prescribed when clinically appropriate.
Giotrif 30 mg tablets: An alternative strength used according to the treating specialist's assessment.
Giotrif 40 mg tablets: The recommended starting dose in the Singapore product information, subject to individual clinical considerations.
Active ingredient: Afatinib (as afatinib dimaleate).
Dosage form: Oral film-coated tablets.
Therapeutic category: Targeted anticancer medicine.
The appropriate strength depends on the patient's diagnosis, tolerability, medical history, and specialist guidance. Patients should not change their dose or strength without consulting their oncologist.
Benefits and Approved Uses of Giotrif
Giotrif works by blocking signalling activity in the ErbB receptor family, including the epidermal growth factor receptor (EGFR). These pathways can contribute to the growth and survival of certain cancer cells.
Its approved uses in Singapore include:
First-line treatment of locally advanced or metastatic NSCLC with qualifying EGFR mutations.
Treatment of locally advanced or metastatic squamous NSCLC that has progressed during or after platinum-based chemotherapy.
The potential benefit is targeted treatment for patients whose cancer characteristics match the approved indication. Treatment suitability should be established through appropriate diagnostic testing and an oncologist's evaluation. Giotrif is not suitable for every type of lung cancer.
Side Effects and Safety Precautions
Common adverse effects may include diarrhoea, skin rash, acne-like skin reactions, mouth inflammation, and reduced appetite. Some reactions may require medical intervention or a dose adjustment.
Seek prompt medical attention for severe or persistent diarrhoea, significant skin reactions, eye problems, or new or worsening breathing difficulties. Serious lung inflammation can occur. Patients should disclose their other medicines and existing medical conditions to their healthcare professional.
Giotrif is a prescription-only medicine in Singapore. Use it strictly according to the approved product information and the prescribing specialist's instructions.
Giotrif Tablets Supply Enquiries in Singapore
Cordium Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company. Healthcare procurement teams and authorised pharmaceutical buyers can contact the company to enquire about product availability, documentation, and potential supply arrangements, subject to applicable regulatory requirements.
Before placing an order, verify the product's registration status, supplier authorisation, product authenticity, batch documentation, and import eligibility in Singapore. Any cross-border supply must comply with applicable Health Sciences Authority (HSA) requirements.
Frequently Asked Questions
1. What strengths of Giotrif tablets are available in Singapore?
The Singapore National Drug Formulary lists Giotrif 20 mg, 30 mg, and 40 mg film-coated tablets.
2. What is Giotrif used for?
It is used for specified forms of locally advanced or metastatic NSCLC, depending on EGFR mutation status or squamous tumour histology and previous treatment.
3. Can I buy Giotrif tablets online in Singapore?
Giotrif is prescription-only. Patients should obtain it through lawful, authorised channels under appropriate medical supervision.
4. Does Cordium Pharmaceuticals supply Giotrif to Singapore?
Contact Cordium Pharmaceuticals Pvt. Ltd. to enquire about current availability and eligible supply arrangements. Product availability and export authorisation should be confirmed before any transaction.
Medical disclaimer: This article is for educational and pharmaceutical product-information purposes only. It does not replace medical advice, a prescription, or regulatory verification.
Keywords
